Navigation Links
Fast-Acting, Long-Lasting Topical Relief From Arthritis Pain
Date:3/11/2009

Medicated Arthri-Zen Relief Cream(R) Clinically Shown to Work for up to 8 Hours

MIAMI, March 11 /PRNewswire/ -- Every day, 70 million Americans suffer from the aches and pains that come with arthritis and other chronic joint problems(1). One of the most effective ways to get fast relief from arthritis pain is the use of analgesic creams. The only problem is that the relief tends to be short-lived. Many people find that within 45 minutes to an hour and a half after applying a cream, the pain comes right back. RZN Nutraceuticals, www.rznnutra.com, has solved that problem, with the development of their soothing, medicated and clinically tested analgesic Arthri-Zen Relief Cream(R). A recent randomized, blinded study found that Arthri-Zen Relief Cream(R) provides fast relief that is shown to last for up to eight hours.

The study recruited 83 adults with physician-diagnosed arthritis, all of whom had had a history of daily arthritis pain for a minimum of six months. For ten days, study subjects applied Arthri-Zen Relief Cream(R) to joint "hot spots" three times a day. They were evaluated by a clinician on the first day and again on the tenth day for conditions such as arthritis, inflammation, swelling, joint stiffness, muscle pain and range of motion. Throughout the study, participants also kept daily pain diaries.

The results were eye-opening: 63% of study subjects got relief from swelling, 93.8% experienced an increase in range of motion, 94.1% got relief from arthritis and inflammation and a full 100% had relief from muscle pain and joint stiffness. All of the results were statistically significant.

However, participants didn't have to wait 10 days to feel an effect. After just five minutes, over a quarter experienced 90-100% relief from their pain. Another 41.3% got 70-89% relief. And another 22.5% had 50-69% relief. The best pa
'/>"/>

SOURCE RZN Nutraceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. NovaBay Pharmaceuticals Announces Lead Anti-infective Product Candidate, NVC-422, Shown to be Effective in Treating Topical Fungal Infection
2. ISTA Pharmaceuticals Announces Phase III Results for Once-Daily Topical Xibrom(TM) 0.09%
3. Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream
4. Topical Treatment for Cold Sores Achieves Efficacy of Oral Drugs; Represents Paradigm Shift in the Treatment of Skin Infections
5. NanoBio Demonstrates New Topical Approach to Treating Nail Fungus That Circumvents Problems with Current Therapy
6. Helix Receives Approval to Open Sites in Germany for its Ongoing Clinical Trial With Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
7. ImQuest Receives Two Year Phase 2 SBIR Grant to Develop Pyrimidinedione Product as an Anti-HIV Topical Microbicide
8. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Prevention of Diabetic Foot Infections
9. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Moderately Infected Diabetic Foot Ulcers
10. Transdel Pharmaceuticals Advances Lead Topical Pain Drug into Phase 3 Program
11. MacroChem Announces Presentation of Pexiganan Phase 3 Study Results for Topical Treatment of Diabetic Foot Infection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 27, 2015  Pharmacyclics, Inc. (NASDAQ: ... study published in the Proceedings of the ... that showed when ibrutinib (IMBRUVICA ® ) was ... suppression of tumor growth was enhanced suggesting a ... hematologic cancers and solid tumors with the combination. ...
(Date:2/27/2015)... , Feb. 27, 2015 Securities lawyers at ... of Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP ) ... share. Concerned SLXP investors are encouraged to contact attorney ... The investigation focuses upon the shareholder value of ... shareholders would receive only $158.00 per share in cash. ...
(Date:2/27/2015)... Feb. 27, 2015  Boston Scientific Corporation (NYSE: ... Barclays 2015 Annual Healthcare Conference on March 10 in ... Dan Brennan , executive vice president and chief financial ... Relations, will participate in a 25-minute question and answer ... approximately 1:05 p.m. ET. Following a 5-minute break, a ...
Breaking Medicine Technology:In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 2In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 3In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 4In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 5In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 6In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 7In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 8In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 9Boston Scientific to Participate in the Barclays 2015 Annual Healthcare Conference 2
... 6, 2012 Savient Pharmaceuticals, Inc. (NASDAQ: SVNT ... permanent J-code, for KRYSTEXXA® (pegloticase) became available on January ... the Centers for Medicare and Medicaid Services (CMS) and ... prescribers of KRYSTEXXA, the first and only U.S. Food ...
...  Endo Pharmaceuticals (Nasdaq: ENDP ) announced today ... with U.S.-based BioDelivery Sciences International (Nasdaq: BDSI ... is a transmucosal form of buprenorphine, a partial mu-opiate ... BEMA Buprenorphine is currently in phase III trials for ...
Cached Medicine Technology:Savient Pharmaceuticals Announces Permanent J-Code Assigned for KRYSTEXXA® 2Savient Pharmaceuticals Announces Permanent J-Code Assigned for KRYSTEXXA® 3Savient Pharmaceuticals Announces Permanent J-Code Assigned for KRYSTEXXA® 4Savient Pharmaceuticals Announces Permanent J-Code Assigned for KRYSTEXXA® 5Savient Pharmaceuticals Announces Permanent J-Code Assigned for KRYSTEXXA® 6Endo Pharmaceuticals and BioDelivery Sciences International Sign Licensing Agreement for BEMA Buprenorphine 2
(Date:2/28/2015)... The MCA Youth Empowerment Conference aims to bridge youths ... towards the goal for a better future for all ... smaller groups will be held after the conference with ... Healthcare, Social and Volunteerism, Women and Youth Empowerment, to ... , Young adults aged between 18-30 years that have ...
(Date:2/28/2015)... TX (PRWEB) March 01, 2015 Heart ... estimated that 10 percent of urban adult population and ... form of heart diseases and 20-30 percent of them ... to heart ailments and coronary vascular diseases (CVD). , ... launched a new market research report titled “Indian Coronary ...
(Date:2/28/2015)... Gerald “Solutionman” Haman surveyed over 10,000 people to discover ... “The #1 block was lack of time and ... who created the Thinkubator Innovation Studio in Chicago. ... did not have enough time for innovative thinking and ... , Solutionman’s monthly “Accelerating Innovation Training” workshops address the ...
(Date:2/28/2015)... Calgary, AB (PRWEB) February 28, 2015 ... and is now a distributor of the machine. The ... part of their license, like a franchise model. The ... people prevent and reverse heart disease. To buy ... Heart Fit Clinic can help individuals through this process ...
(Date:2/28/2015)... February 28, 2015 March—also known ... time to remind ourselves and others that suspected ... Atlantic NeuroSurgical Specialists (ANS). , Concussions are a ... for 75% of TBIs. There are 1.6-3.8 million ... sound benign, but it is a brain injury. ...
Breaking Medicine News(10 mins):Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 2Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 3Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 4Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 3Health News:New Survey Reveals “Lack of Time” Is the Number #1 Barrier to Innovative Thinking 2Health News:New Survey Reveals “Lack of Time” Is the Number #1 Barrier to Innovative Thinking 3Health News:Clinicians Can Now Purchase External Counterpulsation with Heart Fit Clinic 2Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 2Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 3
... PHILADELPHIA, Nov. 6 The American Academy of ... members of Lippincott Williams & Wilkins (LWW) nursing ... Wolters Kluwer Health, a leading provider of information ... in medicine, nursing, allied health, and pharmacy. Academy ...
... groups pay off, study finds , FRIDAY, Nov. ... starting a walking group or creating pedestrian-friendly routes ... study has found. , At a multicultural housing ... interventions meant to increase residents, walking, including sponsoring ...
... St. Michael,s Hospital working in conjunction with EMS services, paramedics ... attempts cardiopulmonary resuscitation (CPR) can quadruple the survival rate to ... research team at Rescu ( www.rescu.ca ) have found only ... help, one of the lowest rates of bystanders helping others ...
... With 125 million Americans challenged by at least one chronic illness ... chronic illnesses, early, smart estate and financial planning can make the ... its exigencies. , WHAT : ... importance for people living with chronic illness and their advisers: ...
... Bermuda, Nov. 6 Allied World Assurance,Company Holdings, ... Allied World U.S.,Nicole Baummer, Assistant Vice President for ... Professional Lines,Claims, will be speaking at this year,s ... held in Chicago, Illinois,November 11-13, 2009. , ...
... tables cleaned less often than toilet seats, study finds ... of restrooms aboard cruise ships raises the risk of ... Norovirus causes about 95 percent of acute gastroenteritis outbreaks ... norovirus outbreaks occurred on 66 ships monitored by the ...
Cached Medicine News:Health News:Seven LWW Nursing Editors Recognized as Leaders by American Academy of Nursing 2Health News:Seven LWW Nursing Editors Recognized as Leaders by American Academy of Nursing 3Health News:Less than 1 in 3 Toronto bystanders who witness a cardiac arrest try to help: Study 2Health News:Less than 1 in 3 Toronto bystanders who witness a cardiac arrest try to help: Study 3Health News:Chronic Illness: Estate Planning 2Health News:Chronic Illness: Estate Planning 3Health News:Chronic Illness: Estate Planning 4Health News:Allied World's Nicole Baummer and Marjorie Thompson to Speak at PLUS International Conference 2Health News:Allied World's Nicole Baummer and Marjorie Thompson to Speak at PLUS International Conference 3Health News:Poor Restroom Cleaning Causes Cruise-Ship Sickness 2
Ascent Primary Knee System with cruciate retaining, posterior stabilized and constrained components...
... solution tricompartmental total knee prosthesis stems from ... State-of-the-art design and manufacturing technologies have been ... function as well as a favorable pressure ... to keep wear to a minimum. The ...
... Foundation PS knee offers a femoral option and ... action that engages at 60 degrees of flexion ... and allow for 130 degrees of flexion. Femoral ... with prominent lateral flare. The constrained tibial insert ...
... BioPro Total Knee system ... anatomical replacement of all ... knee joint, while preserving ... Posterior Ligaments, bone stock, ...
Medicine Products: